S. No. | Title and Authors Name |
---|---|
1 |
Efficacy and safety profile of capecitabine-based regimens in women with metastatic breast cancer
Ahmed Salim Nayyef and Ali Mohammed Jawad
Int. J. Oncol. Res., 2024; 4(1): 85-93
|
2 |
Patient feedback on the ease and success of using telehealth for managing breast cancer
Namdev Jagtap, Dr. DN Hambire, Chhagan Pandurang Khartode, Sushant Vijay Shinde and Dr. Suraj Subhash Ingole
Int. J. Oncol. Res., 2024; 4(1): 94-96
|
3 |
Evaluation of clinical and radiological response with antiangiogenic therapy in advanced hepatocellular carcinoma patients
Noha Mohamed Azab, Rabab Mahmoud Abu-Sobaa, Mohamed Abd-Elhamed Alm Aldin and Fatma Zakria Hussein
Int. J. Oncol. Res., 2024; 4(1): 97-105
|
4 |
A retrospective analysis of outcome with triplet oral metronomic chemotherapy in head and neck cancers in a resource comprising setting during COVID 19 pandemic, a single institute experience
Dr. Raju Mathew Cyriac, Dr. Athira K and Dr. Sivagnanam Balaji
Int. J. Oncol. Res., 2024; 4(1): 106-112
|
5 |
Treatment of dermatofibrosarcoma protuberans and childbirth
S Kunda, Nawfal Azzo, Nagham Ibraheem and Rasha Fadhil Abas
Int. J. Oncol. Res., 2024; 4(1): 113-115
|